{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:25:17Z","timestamp":1717115117001},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jvacx.2024.100487","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T03:21:25Z","timestamp":1713669685000},"page":"100487","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibody responses to SARS-CoV-2 spike protein in a cohort of renal transplant recipients following two-dose primary immunization \u2212 A Caribbean country\u2019s perspective"],"prefix":"10.1016","volume":"18","author":[{"given":"Lesley","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla-Maria","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Monteil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhura","family":"Manjunath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100487_b0005","unstructured":"Mathieu Edouard, Ritchie Hannah, Rodes-Guirao Lucas, Appel Cameron, Giattino Charlie, Hasell Joe, et al. Coronavirus Pandemic (COVID-19) - Trinidad & Tobago [Internet]; 2023. Available from: <https:\/\/ourworldindata.org\/coronavirus> [Online Resource]."},{"key":"10.1016\/j.jvacx.2024.100487_b0010","unstructured":"Lindo P. Sinopharm vaccines arrive in Trinidad and Tobago. Trinidad and Tobago Newsday [Internet]; 2021 May 19; Available from: https:\/\/newsday.co.tt\/2021\/05\/19\/sinopharm-vaccines-arrive-in-trinidad-and-tobago\/."},{"key":"10.1016\/j.jvacx.2024.100487_b0015","unstructured":"Clyne KS. Docs, nurses to get covid19 vaccines from Wednesday. Trinidad and Tobago Newsday [Internet]; 2021 Feb 16; Available from: https:\/\/newsday.co.tt\/2021\/02\/16\/trinidad-covid19-vaccinations-start-wednesday\/."},{"issue":"8","key":"10.1016\/j.jvacx.2024.100487_b0020","doi-asserted-by":"crossref","first-page":"e007096","DOI":"10.1136\/bmjgh-2021-007096","article-title":"Did vaccine inequity lead to the second wave of COVID-19 infections in Trinidad and Tobago?","volume":"6","author":"Maharaj","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.jvacx.2024.100487_b0025","unstructured":"US Embassy Trinidad and Tobago. United States Donates 305,370 Pfizer COVID-19 Vaccine Doses to Trinidad and Tobago [Internet]; 2021. Available from: https:\/\/tt.usembassy.gov\/united-states-donates-305370-pfizer-covid-19-vaccine-doses-to-trinidad-and-tobago\/."},{"issue":"12","key":"10.1016\/j.jvacx.2024.100487_b0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/medicina57121327","article-title":"Immune response after SARS-CoV-2 vaccination in kidney transplant patients","volume":"57","author":"Vaiciuniene","year":"2021","journal-title":"Medicina"},{"issue":"21","key":"10.1016\/j.jvacx.2024.100487_b0035","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-Dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100487_b0040","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/ajt.16615","article-title":"Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus","volume":"21","author":"Grupper","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jvacx.2024.100487_b0045","doi-asserted-by":"crossref","unstructured":"Perkmann T, Perkmann-Nagele N, Koller T, Mucher P, Radakovics A, Marculescu R, et al. Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays. Powell EA, editor. Microbiol Spectr. 2021;9(1): e00247\u201321.","DOI":"10.1128\/Spectrum.00247-21"},{"issue":"7","key":"10.1016\/j.jvacx.2024.100487_b0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jvacx.2024.100487_b0055","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/ajt.16993","article-title":"SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19","volume":"22","author":"Werbel","year":"2022","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.jvacx.2024.100487_b0060","article-title":"Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis","volume":"11","author":"Sharif","year":"2021","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.jvacx.2024.100487_b0065","article-title":"Cellular immunity is critical for assessing COVID-19 vaccine effectiveness in immunocompromised individuals","volume":"26","author":"Paramithiotis","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jvacx.2024.100487_b0070","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S1473-3099(22)00271-7","volume":"22","author":"Munro","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jvacx.2024.100487_b0075","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/v14102299","article-title":"Immune response after the fourth dose of SARS-CoV-2 mRNA vaccine compared to natural infection in three doses\u2019 vaccinated solid organ transplant recipients","volume":"14","author":"Bus\u00e0","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jvacx.2024.100487_b0080","doi-asserted-by":"crossref","unstructured":"Thomson T, Prendecki M, Gleeson S, Martin P, Spensley K, De Aguiar RC, et al. Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients. eClinicalMedicine 2022 Nov; 53:101642.","DOI":"10.1016\/j.eclinm.2022.101642"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136224000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T20:34:41Z","timestamp":1717101281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136224000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":16,"alternative-id":["S2590136224000603"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100487","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody responses to SARS-CoV-2 spike protein in a cohort of renal transplant recipients following two-dose primary immunization \u2212 A Caribbean country\u2019s perspective","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100487"}}